Biopharma Drug Development & Clinical Laboratory Services | Labcorp
Navigate the complexity of drug development with a trusted scientific laboratory.
Advance your program with solutions that inform every development phase and support your targeted therapeutic indications—including emerging treatment modalities.
.jpg)
Biopharma solutions
Nonclinical development
When you need scientific knowledge and experience in toxicology, pharmacology and metabolism, we're here to propel your drug development program forward.
Access scientific advice, risk assessments, program management and regulatory guidance to speed your asset across all phases of development, advancing your mission of developing breakthrough medicines in any modality or therapeutic area.
Explore nonclinical development lab disciplines & areas
- Toxicology
- Pharmacology
- Metabolism
- Discovery
- Programmatic and regulatory strategies
- All nonclinical development
Central lab services
Ground your development decisions with timely insights. Our industry-leading central labs generate more clinical trial data than all other central labs combined and support trials in over 100 countries. Our bioanalytical scientists in both nonclinical and clinical settings will help you anticipate regulatory challenges and offer strategic solutions to guide and enable fast, informed decisions.
Whether you're focused on highly targeted development, such as cell and gene therapies or biologics, or seeking to define clinically relevant indicators via biomarkers, genomics testing or companion diagnostics, we can help you discover, develop and commercialize your next therapeutic.
Explore central lab services modalities & disciplines
- Cell and gene therapies
- Clinical trial enablement
- Bioanalytical
- Biologics
- Biomarkers
- Genomics
- Companion diagnostics
- Regulatory
- All central lab services
Commercialization services
Research and development answers can be elusive, which can result in uncertainty and delays.
Labcorp’s people—who are leaders in science, regulatory, global logistics, study management and more—are ready to consult with you to design biomarker-driven trials with the latest scientific approaches, offer best practices for study setup and specimen routing, and develop your companion diagnostic (CDx).
And once your therapeutic is approved, Labcorp can support your commercialization efforts with CDx, sponsored testing and more to ensure your breakthrough is reaching the right patients.
Explore commercialization services
- Proprietary data & applications
- Companion diagnostics
- Sponsored testing
- All commercialization services
Advancing your next therapy
Labcorp is your gateway to cutting-edge research and drug development.
Support for biopharmaceutical partners, investigator sites and patients is driven by more than 14,000 Labcorp colleagues worldwide.
From drug discovery to clinical trial testing and diagnostic development and commercialization, today’s Labcorp combines the innovations of more than five decades supporting our biopharma partners in bringing new therapies to patients.
76% Labcorp supported 76% of all drugs and therapeutic products approved by the FDA in 2024
86% Labcorp supported 86% of oncology drugs approved by the FDA in 2024
100+ countries where we provide contract research services
Explore our history of biopharmaceutical support
Explore the latest
Expedite drug development and bring new therapies to patients, faster.
Help for increasingly complex clinical trials.
Introducing Global Trial Connect
Exploring antibody drug conjugate development
Global Locations
Access global reach through our comprehensive network of drug development labs.
North America
Flagship locations in Madison (WI) and Indianapolis (IN) are complemented with several specialty labs across the U.S.
Europe
Flagship locations in Harrogate (U.K.) and Geneva (Switzerland) are supported by centers of excellence and kit production throughout Europe, the Middle East and Asia.
Asia-Pacific
Accelerate your drug development goals with our cutting-edge capabilities across China, Japan, Singapore, India, South Korea and the entire Asia Pacific region.